Literature DB >> 25182935

Synthesis and fluorescence study of naphthalimide-coumarin, naphthalimide-luminol conjugates.

T Sheshashena Reddy1, A Ram Reddy.   

Abstract

Fluorescent naphthalimide-coumarin and naphthalimide-luminol conjugates were prepared by nucleophilic substitution reaction. The synthesized conjugates were characterized by (1)H-NMR, (13)C-NMR, mass and IR spectra. The absorption and fluorescence of these conjugates revealed that naphthalimide-luminol conjugates are more fluorescent than the naphthalimide-coumarin conjugates. In proton accepting DMSO solvent the fluorescence of the conjugates was quenched, while in proton donating ethanol solvent enhanced fluorescence was noticed. Based on the excitation maxima and fluorescence maxima it was found that in naphthalimide-coumarin conjugates coumarin acting as donor and naphthalimide acting as acceptor where as in naphthalimide-luminol conjugates naphthalimide acts as donor and luminol acts as acceptor.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25182935     DOI: 10.1007/s10895-014-1440-x

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  9 in total

1.  Novel naphthalimide hydroperoxide photonucleases: the role of thiocyclic-fused area and the difference in spectra, photochemistry and photobiological activity.

Authors:  Yufang Xu; Xuhong Qian; Wei Yao; Ping Mao; Jingnan Cui
Journal:  Bioorg Med Chem       Date:  2003-12-01       Impact factor: 3.641

2.  4-Nitro-1,8-naphthalimides exhibit antinociceptive properties.

Authors:  M M de Souza; R Corrêa; Filho V Cechinel; I Grabchev; V Bojinov
Journal:  Pharmazie       Date:  2002-06       Impact factor: 1.267

3.  Small molecules with antimicrobial activity against E. coli and P. aeruginosa identified by high-throughput screening.

Authors:  R De La Fuente; N D Sonawane; D Arumainayagam; A S Verkman
Journal:  Br J Pharmacol       Date:  2006-09-18       Impact factor: 8.739

4.  Analgesic activity of cyclic imides: 1,8-naphthalimide and 1,4,5,8-naphthalenediimide derivatives.

Authors:  A D Andricopulo; L A Müller; V C Filho; G S Cani; J F Roos; R Corrêa; A R Santos; R J Nunes; R A Yunes
Journal:  Farmaco       Date:  2000-04

5.  Antitrypanosomal activity of quaternary naphthalimide derivatives.

Authors:  Mathias Muth; Verena Hoerr; Melanie Glaser; Alicia Ponte-Sucre; Heidrun Moll; August Stich; Ulrike Holzgrabe
Journal:  Bioorg Med Chem Lett       Date:  2007-01-04       Impact factor: 2.823

Review 6.  Naphthalimides and azonafides as promising anti-cancer agents.

Authors:  Laurent Ingrassia; Florence Lefranc; Robert Kiss; Tatjana Mijatovic
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

7.  Fluorescence ratiometric selective recognition of Cu(2+) ions by dansyl-naphthalimide dyads.

Authors:  Vadakkancheril S Jisha; Anu J Thomas; Danaboyina Ramaiah
Journal:  J Org Chem       Date:  2009-09-04       Impact factor: 4.354

8.  Intramolecular exciplex and intermolecular excimer formation of 1,8-naphthalimide-linker-phenothiazine dyads.

Authors:  Dae Won Cho; Mamoru Fujitsuka; Kyung Hwa Choi; Man Jae Park; Ung Chan Yoon; Tetsuro Majima
Journal:  J Phys Chem B       Date:  2006-03-16       Impact factor: 2.991

9.  Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642).

Authors:  M E Costanza; D Berry; I C Henderson; M J Ratain; K Wu; C Shapiro; D Duggan; J Kalra; I Berkowitz; A P Lyss
Journal:  Clin Cancer Res       Date:  1995-07       Impact factor: 12.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.